Company Name | Contact Info | Location | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ZET MEDİKAL TEKSTİL DIŞ TİC. LTD. ŞTİ.
Y.DUDULLU MAH. NECİP FAZIL BULVARI KEYAP SİTESİ B2 BLOK 44/26 / ÜMRANİYE / İSTANBUL / TÜRKİYE
|
Contact Info: +90 505 395 8382
|
Hall: 3
Stand: 332D
|
||||||||||||
Product Groups | ||||||||||||||
|
- Company Info
- Products
- Represented Companies
- Company Brands
Zet Medical ltd commercial applications started in 2007 with the import of commercial medical and diagnostic applications(pregnancy test, urine strips). It can be developed tp produce in production in 2017. The product and processing applications to be used for the evaluation of people and evaluation process. Production of Zet medical products in preparation for ISO 134852016 and CE directive. In addition, company offer Private Label(contact manufacturing), OEM and OBL product services.
SOFTEC COVID-19 RT-qPCR Kit is used for the qualitative detection of the SARS-CoV-2 (2019-nCoV) virus by RNA obtained from human nasopharyngeal swab, oropharyngeal swab, nasal swab, and oral/saliva swab samples.
It allows the detection of genomic materials of sexually transmitted disease types by RT-qPCR method. Disease-type-specific primers are used for amplification of target sequences, and target-specific probes are used for detection of amplified cDNA.
The kit allows the detection of genomic materials of pathogens in the targeted urogenital mycoplasma panel by RT-qPCR method. Pathogen-specific primers included in the urogenital mycoplasma panel are used for amplification of target sequences, and target-specific probes are used for detection of amplified cDNA.
It allows the detection of HSV-1 and HSV-2 genomic materials by RT-qPCR method. Primers specific for HSV-1 and HSV-2 are used for amplification of target sequences, and target-specific probes are used for detection of amplified cDNA.
Softec Sars Cov-2 Antigen Test Kit (Nasal Swab) is a lateral flow immunoassay intended for the qualitative detection SARS-CoV-2 nucleocapsid antigens in nasal swab from individuals who are suspected of COVID-19 by their healthcare provider.
No represented companies found.
- SOFTEC